Side-by-side comparison of AI visibility scores, market position, and capabilities
London D2C e-commerce OS (founded 2022); $40M ICONIQ Growth Series B (March 2025) after 7x revenue growth with Importer of Record model serving 500+ fashion brands ($20M-$100M) competing with Global-e for cross-border operations.
Swap is a London, United Kingdom-based e-commerce operating system for direct-to-consumer brands — backed with approximately $49 million in total funding including a $40 million Series B in March 2025 led by ICONIQ Growth with Cherry Ventures, QED Investors, and 9900 Capital — providing a unified platform for cross-border logistics, inventory management, and international operations that reduces operational costs by up to 30% and improves revenue by 8% for 500+ fashion, eyewear, and lifestyle brands. Founded in 2022 by CEO Sam Atkinson and CPO Zach Bailet (whose direct experience running a cross-border e-commerce business sourcing from Africa informed the platform's design), Swap achieved 7x revenue growth between March 2024 and March 2025. Brands including 3.1 Phillip Lim, Sandy Liang, Ed Hardy, Pangaia, The Frankie Shop, and Odd Muse (typically $20M-$100M annual sales) rely on Swap for Importer of Record services, delivered duty paid (DDP) shipping, automated tax remittance, and express customs clearance across 190+ countries. Swap Inventory (AI-powered demand forecasting and smart restocking) launched in 2025 alongside expansion to Australia and Canada.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.